Engine Biosciences

company

About

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$43M
Industries
Artificial Intelligence,Biotechnology,Health Care,Machine Learning
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming.

This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$53M
Engine Biosciences has raised a total of $53M in funding over 2 rounds. Their latest funding was raised on May 26, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 26, 2021 Series A $43M 1 Detail
Jan 31, 2018 Seed $10M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Engine Biosciences has made 1 investments. Their most recent investment was on Feb 24, 2017, when Manticore Games raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 24, 2017 Manticore Games
Seed Console Games

Investors

Number of Lead Investors
Number of Investors
1
Engine Biosciences is funded by 1 investors. Goodman Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Goodman Capital Series A